Leica Biosystems to Acquire Devicor Medical Products, Inc.

Buffalo Grove, Illinois (ots/PRNewswire) -

Leica Biosystems, a global leader in anatomic pathology laboratory
solutions and instruments, announced today that it has successfully
completed its previously announced acquisition of Devicor Medical
Products, Inc.

Devicor is a global market leader in breast biopsy instruments and
consumables, with annual revenues of approximately $170 million. It
is committed to advancing technology to help clinicians accurately
diagnose breast disease, such as breast cancer, through minimally
invasive procedures. Among Devicor's products is the Original
Mammotome Breast Biopsy System, which, to date, has enabled more than
four million women to have a minimally invasive breast biopsy.

"Leica's Biosystems' products and solutions address the key steps
across the anatomic pathology laboratory workflow. The addition of
Devicor's market leading breast biopsy products, especially
Mammotome, allows us to further integrate that workflow from the
source, starting with the patient and the biopsy sample," said
Matthias Weber, MD, President of Leica Biosystems. "This acquisition
supports our mission of advancing cancer diagnostics to improve lives
by adding products that will have direct benefits for the patients
and the clinicians who care for them."

Devicor will operate as a standalone business within Leica
Biosystems and will continue to be led by Tom Daulton, the current
CEO of Devicor. No other financial terms and conditions have been
disclosed.

About Leica Biosystems

Leica Biosystems, is a global leader in anatomic pathology
workflow solutions and automation, striving to advance cancer
diagnostics to improve patients' lives. Leica Biosystems provides
anatomic pathology laboratories and researchers a comprehensive
product range for each step in the pathology process, from sample
preparation and staining to imaging and reporting. Leica Biosystems'
easy-to-use and consistently reliable offerings help improve workflow
efficiency and diagnostic confidence. The company is represented in
over 100 countries. It has manufacturing facilities in 8 countries,
sales and service organizations in 27 countries, and a network of
dealers spanning the globe. The company is headquartered in Nussloch,
Germany. Visit http://www.LeicaBiosystems.com for more information.

LEICA and the Leica logo are registered trademarks of Leica
Microsystems IR GmbH.

Devicor and Mammotome are registered trademarks of Devicor, Inc.

Contact: Diane Mielnikowski
Phone: +1-847-821-3446
Email: Diane.Mielnikowski@leicabiosystems.com

ots Originaltext: Leica Biosystems Ltd
Im Internet recherchierbar: http://www.presseportal.de